1. Home
  2. VOR vs GCO Comparison

VOR vs GCO Comparison

Compare VOR & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VOR
  • GCO
  • Stock Information
  • Founded
  • VOR 2015
  • GCO 1924
  • Country
  • VOR United States
  • GCO United States
  • Employees
  • VOR N/A
  • GCO N/A
  • Industry
  • VOR Biotechnology: Pharmaceutical Preparations
  • GCO Clothing/Shoe/Accessory Stores
  • Sector
  • VOR Health Care
  • GCO Consumer Discretionary
  • Exchange
  • VOR Nasdaq
  • GCO Nasdaq
  • Market Cap
  • VOR 202.4M
  • GCO 212.2M
  • IPO Year
  • VOR 2021
  • GCO N/A
  • Fundamental
  • Price
  • VOR $2.42
  • GCO $22.50
  • Analyst Decision
  • VOR Buy
  • GCO Hold
  • Analyst Count
  • VOR 7
  • GCO 2
  • Target Price
  • VOR $3.77
  • GCO $24.50
  • AVG Volume (30 Days)
  • VOR 47.5M
  • GCO 241.0K
  • Earning Date
  • VOR 08-07-2025
  • GCO 09-05-2025
  • Dividend Yield
  • VOR N/A
  • GCO N/A
  • EPS Growth
  • VOR N/A
  • GCO N/A
  • EPS
  • VOR N/A
  • GCO N/A
  • Revenue
  • VOR N/A
  • GCO $2,341,438,000.00
  • Revenue This Year
  • VOR N/A
  • GCO $2.53
  • Revenue Next Year
  • VOR N/A
  • GCO $2.01
  • P/E Ratio
  • VOR N/A
  • GCO N/A
  • Revenue Growth
  • VOR N/A
  • GCO 1.85
  • 52 Week Low
  • VOR $0.13
  • GCO $16.19
  • 52 Week High
  • VOR $3.29
  • GCO $44.80
  • Technical
  • Relative Strength Index (RSI)
  • VOR 73.52
  • GCO 52.29
  • Support Level
  • VOR $2.25
  • GCO $21.26
  • Resistance Level
  • VOR $2.84
  • GCO $24.63
  • Average True Range (ATR)
  • VOR 0.54
  • GCO 1.06
  • MACD
  • VOR 0.10
  • GCO 0.20
  • Stochastic Oscillator
  • VOR 70.92
  • GCO 57.49

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

About GCO Genesco Inc.

Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.

Share on Social Networks: